“…We identified 51, 87, and 73 potential direct RFX7 targets in U2OS, HCT116, and RPE-1 cells, respectively, and these direct RFX7 targets include PDCD4 , PIK3IP1 , MXD4 , and PNRC1 (Figure 4D). Most strikingly, target genes up-regulated through the p53-RFX7 axis comprise additional tumor suppressor genes, such as ABAT (65), CCNG2 (66), IP6K2 (67), OTUD5 (68), REV3L (69), RPS6KA5 (also known as MSK1 ) (70), TOB1 (71), TSC22D1 (72), and TSPYL2 (73). Most direct RFX7 targets were up-regulated in response to Nutlin-3a treatment in siControl-transfected cells, and the up-regulation was impaired or abrogated when RFX7 was depleted (Figure 4D).…”